Carl Zeiss Meditec AG
CZMWF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.74 | -0.92 | -21.08 | 1.29 |
| FCF Yield | 5.41% | 1.51% | 1.84% | 1.14% |
| EV / EBITDA | 9.34 | 28.54 | 15.12 | 19.54 |
| Quality | ||||
| ROIC | 6.58% | 3.19% | 10.53% | 14.70% |
| Gross Margin | 52.76% | 52.69% | 57.71% | 59.26% |
| Cash Conversion Ratio | 1.73 | 1.37 | 0.86 | 0.64 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.75% | 2.78% | 8.26% | 12.53% |
| Free Cash Flow Growth | 110.30% | -30.57% | 28.97% | -64.18% |
| Safety | ||||
| Net Debt / EBITDA | 0.25 | 0.58 | 0.29 | 0.25 |
| Interest Coverage | 11.32 | 4.12 | 170.74 | 44.51 |
| Efficiency | ||||
| Inventory Turnover | 2.48 | 1.82 | 1.70 | 2.03 |
| Cash Conversion Cycle | 202.85 | 234.69 | 189.23 | 170.60 |